VIROPRO INC. Inactive Instrument
Viropro Inc. Stock Other OTC
Equities
VPRO
US9282422057
Biotechnology & Medical Research
More news
More press releases
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 16-01-07 |
| Director/Board Member | - | 12-10-18 |
Viropro, Inc. is engaged in the development and manufacturing of biopharmaceutical drugs. The Company conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The Company intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.16% | 103B | |
| +1.80% | 96.56B | |
| +1.72% | 22.61B | |
| -17.58% | 21.18B | |
| -4.50% | 19.07B | |
| -41.75% | 16.53B | |
| -25.07% | 14.46B | |
| +2.22% | 13.25B | |
| +22.20% | 11.1B |
